Back to User profile » Dr Huiling Cao
Paper published by Dr Huiling Cao:
Original Research
Targeting CD20 in Primary Membranous Nephropathy Serologically and Histologically Negative for PLA2R: Is Obinutuzumab Superior to Rituximab?
Cao H, Feng Y, Li X, Ke B, Gong L
Drug Design, Development and Therapy 2025, 19:9983-9992
Published Date: 7 November 2025